Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis.

IF 3.3 Q2 GASTROENTEROLOGY & HEPATOLOGY
Jieqi Zheng, Zinan Fan, Chao Li, Daiyue Wang, Shenghong Zhang, Rirong Chen
{"title":"Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis.","authors":"Jieqi Zheng, Zinan Fan, Chao Li, Daiyue Wang, Shenghong Zhang, Rirong Chen","doi":"10.1136/bmjgast-2024-001587","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Acute severe ulcerative colitis (ASUC) poses challenges to patient management owing to its high surgical rate. This study aimed to identify predictors of colectomy in patients with ASUC.</p><p><strong>Design: </strong>This is a systematic review and meta-analysis.</p><p><strong>Data sources: </strong>PubMed and Web of Science were searched up to April 2024.</p><p><strong>Eligibility criteria: </strong>Studies on the predictors of colectomy in adult patients with ASUC were eligible.</p><p><strong>Data extraction and synthesis: </strong>Two reviewers independently extracted the data using a prespecified data collection sheet. A qualitative synthesis was performed in tabular form. Random-effect meta-analyses were conducted using OR and 95% CI.</p><p><strong>Results: </strong>Forty-two studies were included in the systematic review. The reported variables can be categorised into biomarkers, auxiliary examination findings, demographic and clinical characteristics, and drug factors. Through meta-analysis, albumin (OR 0.39 (95% CI 0.26 to 0.59) per 1 g/dL increment, I<sup>2</sup>=0.0%), high C reactive protein level (2.63 (1.53 to 4.52), I<sup>2</sup>=29.6%), high erythrocyte sedimentation rate level (2.92 (1.39 to 6.14), I<sup>2</sup>=0.0%), low haemoglobin level (2.08 (1.07 to 4.07), I<sup>2</sup>=56.4%), fulfilling the Oxford criteria (4.42 (2.85 to 6.84), I<sup>2</sup>=0.0%), extensive colitis (1.85 (1.24 to 2.78), I<sup>2</sup>=47.5%), previous steroids (1.75 (1.23 to 2.50), I<sup>2</sup>=17.7%) or azathioprine (2.25 (1.28 to 3.96), I<sup>2</sup>=0.0%) use, and sarcopenia (1.90 (1.04 to 3.45), I<sup>2</sup>=0.0%) were identified as valuable predictors for colectomy within 1 year. The ulcerative colitis endoscopic index of severity (OR 2.41 (95% CI 1.72 to 3.39), I<sup>2</sup>=1.5%) was the only predictor found to predict colectomy over 1 year.</p><p><strong>Conclusion: </strong>Identification of these predictors may facilitate risk stratification of patients with ASUC, drive personalised treatment and reduce the need for colectomy.</p>","PeriodicalId":9235,"journal":{"name":"BMJ Open Gastroenterology","volume":"11 1","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575343/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjgast-2024-001587","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Acute severe ulcerative colitis (ASUC) poses challenges to patient management owing to its high surgical rate. This study aimed to identify predictors of colectomy in patients with ASUC.

Design: This is a systematic review and meta-analysis.

Data sources: PubMed and Web of Science were searched up to April 2024.

Eligibility criteria: Studies on the predictors of colectomy in adult patients with ASUC were eligible.

Data extraction and synthesis: Two reviewers independently extracted the data using a prespecified data collection sheet. A qualitative synthesis was performed in tabular form. Random-effect meta-analyses were conducted using OR and 95% CI.

Results: Forty-two studies were included in the systematic review. The reported variables can be categorised into biomarkers, auxiliary examination findings, demographic and clinical characteristics, and drug factors. Through meta-analysis, albumin (OR 0.39 (95% CI 0.26 to 0.59) per 1 g/dL increment, I2=0.0%), high C reactive protein level (2.63 (1.53 to 4.52), I2=29.6%), high erythrocyte sedimentation rate level (2.92 (1.39 to 6.14), I2=0.0%), low haemoglobin level (2.08 (1.07 to 4.07), I2=56.4%), fulfilling the Oxford criteria (4.42 (2.85 to 6.84), I2=0.0%), extensive colitis (1.85 (1.24 to 2.78), I2=47.5%), previous steroids (1.75 (1.23 to 2.50), I2=17.7%) or azathioprine (2.25 (1.28 to 3.96), I2=0.0%) use, and sarcopenia (1.90 (1.04 to 3.45), I2=0.0%) were identified as valuable predictors for colectomy within 1 year. The ulcerative colitis endoscopic index of severity (OR 2.41 (95% CI 1.72 to 3.39), I2=1.5%) was the only predictor found to predict colectomy over 1 year.

Conclusion: Identification of these predictors may facilitate risk stratification of patients with ASUC, drive personalised treatment and reduce the need for colectomy.

急性重度溃疡性结肠炎患者进行结肠切除术的预测因素:系统综述和荟萃分析。
目的:急性重度溃疡性结肠炎(ASUC)手术率高,给患者管理带来挑战。本研究旨在确定ASUC患者进行结肠切除术的预测因素:这是一项系统回顾和荟萃分析:数据来源:搜索了截至 2024 年 4 月的 PubMed 和 Web of Science:数据提取和综合:两名审稿人使用预先指定的数据收集表独立提取数据。以表格形式进行定性综合。使用OR和95% CI进行随机效应荟萃分析:有 42 项研究被纳入系统综述。报告的变量可分为生物标志物、辅助检查结果、人口统计学和临床特征以及药物因素。通过荟萃分析,白蛋白(每增加 1 g/dL OR 0.39(95% CI 0.26 至 0.59),I2=0.0%)、高 C 反应蛋白水平(2.63(1.53 至 4.52),I2=29.6%)、红细胞沉降率水平高(2.92(1.39 至 6.14),I2=0.0%)、血红蛋白水平低(2.08(1.07 至 4.07),I2=56.4%)、符合牛津标准(4.42(2.85 至 6.84),I2=0.0%)、广泛结肠炎(1.85(1.24 至 2.78),I2=47.5%)、曾使用类固醇(1.75(1.23 至 2.50),I2=17.7%)或硫唑嘌呤(2.25(1.28 至 3.96),I2=0.0%)的使用以及肌肉疏松症(1.90(1.04 至 3.45),I2=0.0%)被确定为 1 年内进行结肠切除术的有价值预测因素。溃疡性结肠炎内镜严重程度指数(OR 2.41 (95% CI 1.72 to 3.39),I2=1.5%)是唯一可预测一年内是否进行结肠切除术的预测因子:这些预测因子的确定有助于对 ASUC 患者进行风险分层,推动个性化治疗并减少结肠切除术的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Open Gastroenterology
BMJ Open Gastroenterology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
5.90
自引率
3.20%
发文量
68
审稿时长
2 weeks
期刊介绍: BMJ Open Gastroenterology is an online-only, peer-reviewed, open access gastroenterology journal, dedicated to publishing high-quality medical research from all disciplines and therapeutic areas of gastroenterology. It is the open access companion journal of Gut and is co-owned by the British Society of Gastroenterology. The journal publishes all research study types, from study protocols to phase I trials to meta-analyses, including small or specialist studies. Publishing procedures are built around continuous publication, publishing research online as soon as the article is ready.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信